Product Description
Mechanisms of Action: Epump Modulator
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: YM BioSciences
Company Location: MISSISSAUGA A6 00000
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 2: Breast Cancer
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| YMB1002 202 | P1 |
Completed |
Breast Cancer |
2006-01-01 |
|
| YMB1002 203 | P2 |
Completed |
Breast Cancer |
None |